Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases
2023 · BMC Infectious Diseases · 44 citations
https://doi.org/10.1186/s12879-023-08147-6
H
Hongliu Cai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
5.8K
Citations
21
h-index
28
i10-index
Hongliu Cai is an academic researcher from Hangzhou First People's Hospital. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Antibiotic Resistance in Bacteria. The author has an h-index of 21, co-authored 70 publications.
ORCID: 0000-0003-3783-8328Papers by this author
worksClinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization
2024 · CHEST Journal · 25 citations
https://doi.org/10.1016/j.chest.2024.07.140
Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
2022 · Critical Care · 22 citations
https://doi.org/10.1186/s13054-022-04032-x
Phlorizin, a novel caloric restriction mimetic, stimulates hypoxia and protects cardiomyocytes through activating autophagy via modulating the Hif-1α/Bnip3 axis in sepsis-induced myocardial dysfunction
2023 · International Immunopharmacology · 14 citations
https://doi.org/10.1016/j.intimp.2023.111241
MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibility
2024 · iMeta · 11 citations
https://doi.org/10.1002/imt2.218
The Landscape of lower respiratory tract herpesviruses in severe pneumonia patients: a multicenter, retrospective study with prospective validation
2025 · Critical Care · 11 citations
https://doi.org/10.1186/s13054-025-05496-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat